Related Articles
Mutational analysis of the insulin‑like growth factor 1 receptor tyrosine kinase domain in non-small cell lung cancer patients
Altered expression of cellular proliferation, apoptosis and the cell cycle-related genes in lung cancer cells with acquired resistance to EGFR tyrosine kinase inhibitors
Frequency and significance of epidermal growth factor receptor mutations detected by PCR methods in patients with non‑small cell lung cancer
Continuous exposure of non‑small cell lung cancer cells with wild‑type EGFR to an inhibitor of EGFR tyrosine kinase induces chemoresistance by activating STAT3
Structural analysis of the EGFR TK domain and potential implications for EGFR targeted therapy